|
02.10.2013 23:46:00
|
Pharmaceutical Research Associates, Inc. -- Correction to Text, August 30, 2013 Release: Moody's Confirms PRA's B2; outlook negative
New York, October 02, 2013 -- In the list of affected ratings for issuer Pharmaceutical Research Associates, Inc., added following heading above the bank credit facility ratings: "The following ratings were affirmed and will be withdrawn at the close of the transaction." The updated debt list for Pharmaceutical Research Associates, Inc. now reads as follows:
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.